http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019272919-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b017d90a74a3ad34390f0e971fcedd4e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F17-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F40-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04W4-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H80-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04W4-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60
filingDate 2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_954df1f2768c539b2df28c16ddd4f993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0838e9bccabb059a9fecd76871736332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55383f2efcec7873932d07eeb39ea167
publicationDate 2019-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019272919-A1
titleOfInvention Proactive follow-up of clinical findings
abstract A framework for facilitating proactive follow-up of clinical findings. In accordance with one aspect, one or more clinical findings that require follow-up are extracted from one or more documents. One or more follow-up activities that are relevant to the one or more clinical findings are determined. Priority levels may be generated for the one or more follow-up activities. The one or more clinical findings, follow-up activities and priority levels may then be displayed in a user interface. A notification may be sent to a recipient to initiate at least one of the one or more follow-up activities.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021217535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11398232-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022044777-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115907265-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022068396-A1
priorityDate 2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24857

Total number of triples: 35.